Since DDX5 acts as an oncogene in breast cancer, the significance of the interaction with DDX5 is unclear, since it was reported that the RNA helicases DDX5 and DDX17 are positive regulators of the transcription activity of MYOD1 [155]. Here, DDX5 is linked to breast carcinoma.